Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 585 shares at $46.76 ($27K) on 2023-06-30, disclosed to the SEC on 2023-06-30.
Scheduled sale ($27k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |